Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio(NUVB) | 15,072,340 | 14,072,340 | -1,000,000 | 22,759 | 51,223 | 33.05% | +28,464 |
| Lexeo Therapeutics | 2,157,623 | 2,355,904 | +198,281 | 28,955 | 36,941 | 23.83% | +7,985 |
| enGene Holdings Inc. COM | 1,131,175 | 1,076,357 | -54,818 | 10,441 | 18,244 | 11.77% | +7,804 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 3,443 | 8,438 | 5.44% | +4,995 |
| enGene Holdings Inc. *W EXP 10/31/202 | 475,077 | 360,903 | -114,174 | 404 | 1,877 | 1.21% | +1,473 |
| Senti Biosciences, Inc. | 195,792 | 0 | -195,792 | 129 | 0 | — | -129 |
| Immunic Inc | 1,788,160 | 1,788,160 | 0 | 2,682 | 2,360 | 1.52% | -322 |
| Syros Pharmaceuticals | 251,270 | 251,270 | 0 | 1,957 | 1,344 | 0.87% | -613 |
| Replimune Group(REPL) | 3,001,319 | 3,001,319 | 0 | 25,301 | 24,521 | 15.82% | -780 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 4,431 | 3,194 | 2.06% | -1,237 |
| Theseus Pharmaceuticals | 711,479 | 0 | -711,479 | 2,881 | 0 | — | -2,881 |
| Morphic Holding | 309,846 | 159,846 | -150,000 | 8,948 | 5,627 | 3.63% | -3,322 |
| Kronos Bio | 3,818,283 | 955,866 | -2,862,417 | 4,773 | 1,243 | 0.80% | -3,530 |
| Spruce Biosciences | 2,161,022 | 0 | -2,161,022 | 6,332 | 0 | — | -6,332 |